Setidegrasib in KRAS G12D-Mutant NSCLC and Pancreatic Cancer: A New Frontier Opens in Precision Oncology
20 Posts Not To Miss From EBCC 2026
China Approves Trastuzumab Deruxtecan (ENHERTU) Followed by THP for Neoadjuvant HER2-Positive Breast Cancer Based on DESTINY-Breast11
Jasmine Kamboj: Super Successful First Advocacy Day at The State Capitol with MSCO
Cardio-Oncology Sessions at ACC26 - ICOS
Open Plenary Session of the Common Sense Oncology Leadership Meeting
Building a Future Without Breast Cancer: vraniCURE & MBCure
Yvonne Awards 2026
